Multiple sclerosis
MS treatment, rehab and research.
- Multiple sclerosis26 Aug
A Redditch man plans to cycle the length of the UK without sleeping to raise awareness and funds for the MS Society. Max Williams plans to travel from Land’s End to John O’Groats as the first stage of a wider challenge in which he hopes to cycle through six countries in six months without sleep. [...]
- Stroke18 Aug
A stroke drug may help preserve and repair myelin damaged by multiple sclerosis, according to a review of animal studies. Nimodipine was also linked to reduced inflammation, nerve damage and disease severity in several of the studies reviewed. Myelin is the protective coating around nerve fibres that is damaged in multiple sclerosis, or MS, disrupting [...]
- Multiple sclerosis14 Aug
The FDA has cleared a Phase 2 trial of Lucid-MS, allowing the experimental oral therapy to be tested in people with multiple sclerosis for the first time. The investigational treatment is designed to protect and repair myelin, the fatty sheath surrounding nerve fibres that is damaged in multiple sclerosis. An earlier Phase 1 study involving [...]
- Multiple sclerosis12 Aug
People with multiple sclerosis (MS) who take part in structured exercise programmes tend to report lower levels of fatigue, according to an umbrella review. The strongest evidence was found for cardiorespiratory exercise. Resistance training, which often involves weights or resistance bands, was also linked to lower self-reported fatigue, although results varied more between studies. Fatigue [...]
- Multiple sclerosis7 Aug
Vitamin C supplements are linked to a lower risk of developing MS, particularly among people with a higher genetic predisposition, a study suggests. The apparent benefit was seen in people with a genetic predisposition to the condition. Researchers stressed that further work is needed to confirm the findings. MS is marked by [...]
- Multiple sclerosis6 Aug
Grey matter damage is linked to a higher risk of worsening disability, cognitive impairment and death in people with multiple sclerosis (MS), a study suggests. The damage was more consistently linked to long-term outcomes than damage to white matter, the other main type of brain tissue. The findings offer new insight into how MRI scans [...]
- Multiple sclerosis5 Aug
Scientists have identified a blood marker that could help doctors track the slow, silent progression of multiple sclerosis (MS) and monitor whether treatments are working - even in patients who are not experiencing relapses. The discovery, led by researchers at the University of Basel in Switzerland, focuses on a protein called glial fibrillary acidic protein [...]
- Multiple sclerosis3 Aug
Four Xenia Property Group employees completed a charity fitness challenge in Manchester to support the MS Society. Head of lettings Jennifer Brown, senior lettings negotiator Liam Lowe, senior estates manager Jae Manwaring and marketing coordinator Kirsty Johnston took part in the first DEKA IGNITE team event at Manchester Central. The challenge featured 10 running and [...]
- Multiple sclerosis30 Jul
An eight-year £2.72m AI project aims to improve personalised MS care by learning from information already collected in hospitals. The Wellcome-funded Data-driven Representation Learning for Equitable, Personalised Care in Multiple Sclerosis project, known as DreaMS, will develop AI tools to make better use of decades of existing hospital data. The project will [...]
- Multiple sclerosis29 Jul
Certain diets may support cognition in people with multiple sclerosis, although the evidence remains too limited for firm recommendations. Studies of the low-fat Swank and Wahls diets reported improvements in processing speed and self-perceived cognitive function. Evidence for the Mediterranean diet was mixed, while small studies suggested possible benefits from ketogenic diets and time-restricted eating. [...]












